Submission Details
| 510(k) Number | K053073 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | November 01, 2005 |
| Decision Date | March 28, 2006 |
| Days to Decision | 147 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
Cleared
Traditional
N ANTISERA TO HUMAN ALPHA2-MACROGLOBULIN
Mar 2006
Decision
147d
Days
Class 2
Risk
About This 510(k) Submission
K053073 is an FDA 510(k) clearance for the N ANTISERA TO HUMAN ALPHA2-MACROGLOBULIN, a Alpha-2-macroglobulin, Antigen, Antiserum, Control (Class II — Special Controls, product code DEB), submitted by Dade Behring, Inc. (Newark,, US). The FDA issued a Cleared decision on March 28, 2006, 147 days after receiving the submission on November 1, 2005. This device falls under the Immunology review panel. Regulated under 21 CFR 866.5620.
Device Classification
| Product Code | DEB — Alpha-2-macroglobulin, Antigen, Antiserum, Control |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.5620 |
Manufacturer
Similar Devices — DEB Alpha-2-macroglobulin, Antigen, Antiserum, Control
All 12
K140664 · The Binding Site Group , Ltd.
· Apr 2014
K081249 · Dade Behring, Inc.
· Jul 2008
K974564 · Beckman Instruments, Inc.
· Feb 1998
K914389 · The Binding Site, Ltd.
· Dec 1991
K896483 · Kallestad Diag, A Div. of Erbamont, Inc.
· Dec 1989
K850683 · Kent Laboratories, Inc.
· Nov 1985
More from Dade Behring, Inc.
View all
K093848
· GGN · Dec 2010
K081161
· CFN · Jul 2008
K081249
· DEB · Jul 2008
K071603
· DHX · Jun 2008
K071597
· LOJ · Jun 2008